DTIL Precision Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: DTIL

Price (delayed)

$6.36

Market cap

$175.55M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.27

Enterprise value

$91.24M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 37
Highlights
DTIL's EPS has soared by 87% year-on-year and by 41% since the previous quarter
DTIL's debt is down by 4.6% YoY
Precision Biosciences's quick ratio has surged by 155% YoY but it has decreased by 6% QoQ
The company's equity fell by 40% QoQ but it rose by 33% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.precisionbiosciences.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of DTIL

DTIL stock price

How has the Precision Biosciences stock price performed over time
Intraday
-11.54%
1 week
-4.07%
1 month
-28.14%
1 year
30.33%
YTD
52.88%
QTD
-19.08%

Financial performance

How have Precision Biosciences's revenue and profit performed over time
Revenue
$45.06M
Gross profit
$45.06M
Operating income
-$36.4M
Net income
-$52.73M
Gross margin
100%
Net margin
-117%
The operating margin has soared by 99% year-on-year and by 7% since the previous quarter
DTIL's net margin has soared by 98% YoY but it is down by 21% QoQ
DTIL's operating income has soared by 60% YoY and by 7% QoQ
The company's net income rose by 33% YoY but it fell by 21% QoQ

Price vs fundamentals

How does DTIL's price correlate with its fundamentals

Growth

What is Precision Biosciences's growth rate over time

Valuation

What is Precision Biosciences stock price valuation
P/E
N/A
P/B
3.62
P/S
3.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.03
DTIL's EPS has soared by 87% year-on-year and by 41% since the previous quarter
DTIL's P/B is 86% above its 5-year quarterly average of 2.2 and 52% above its last 4 quarters average of 2.7
The company's equity fell by 40% QoQ but it rose by 33% YoY
The P/S is 84% lower than the last 4 quarters average of 25.6 and 53% lower than the 5-year quarterly average of 8.7

Efficiency

How efficient is Precision Biosciences business performance
DTIL's ROS has soared by 98% year-on-year but it is down by 22% since the previous quarter
Precision Biosciences's return on equity has increased by 40% YoY but it has decreased by 15% QoQ
Precision Biosciences's ROA has increased by 32% YoY but it has decreased by 17% from the previous quarter
The return on invested capital has declined by 27% since the previous quarter but it is up by 19% year-on-year

Dividends

What is DTIL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DTIL.

Financial health

How did Precision Biosciences financials performed over time
Precision Biosciences's total assets is 56% more than its total liabilities
Precision Biosciences's quick ratio has surged by 155% YoY but it has decreased by 6% QoQ
DTIL's current ratio has surged by 147% year-on-year but it is down by 9% since the previous quarter
DTIL's debt is 38% lower than its equity
The debt to equity has surged by 68% since the previous quarter but it has declined by 28% year-on-year
The company's equity fell by 40% QoQ but it rose by 33% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.